Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is a long-acting non-depolarizing muscle relaxant?

Pancuronium. ### Explanation **Pancuronium** is the correct answer because it is a classic **long-acting** steroid-based non-depolarizing neuromuscular blocking agent (NMBA). It typically has a duration of action exceeding 60–90 minutes. It works by competitively antagonizing nicotinic acetylcholine receptors at the neuromuscular junction. **Analysis of Options:** * **Succinylcholine (Option A):** This is a **depolarizing** muscle relaxant. It is known for its rapid onset (30–60 seconds) and ultra-short duration (5–10 minutes), making it the drug of choice for rapid sequence induction (RSI). * **Mivacurium (Option B):** This is a non-depolarizing NMBA, but it is categorized as **short-acting** (duration ~15–20 minutes). It is unique because it is metabolized by plasma cholinesterase. * **Phenylephrine (Option D):** This is not a muscle relaxant; it is a selective **alpha-1 adrenergic agonist** used as a vasopressor to treat hypotension. **High-Yield NEET-PG Pearls:** 1. **Vagolytic Effect:** Pancuronium is notorious for causing **tachycardia** because it inhibits muscarinic receptors in the SA node. This makes it useful in pediatric cardiac surgery but risky in patients with CAD. 2. **Metabolism:** Pancuronium is primarily excreted by the **kidneys** (up to 80%); therefore, its duration is significantly prolonged in patients with renal failure. 3. **Classification by Duration:** * **Short-acting:** Mivacurium. * **Intermediate-acting:** Vecuronium, Atracurium, Cisatracurium, Rocuronium. * **Long-acting:** Pancuronium, Pipecuronium, Doxacurium. 4. **Hoffmann Elimination:** Remember that **Atracurium and Cisatracurium** undergo spontaneous degradation (Hoffmann elimination), making them the drugs of choice in liver and kidney failure.

Q: Latanoprost is a relatively newer agent. Which of the following statements is true regarding this agent?

It is a PGF2a derivative used in glaucoma.. **Explanation:** **Latanoprost** is a high-yield topic in Ophthalmic Pharmacology. It is a **Prostaglandin F2α (PGF2α) analogue** that acts as a selective agonist at the FP receptor. It is primarily used as a first-line treatment for **Open-Angle Glaucoma (OAG)** and Ocular Hypertension. Its mechanism of action involves increasing the **uveoscleral outflow** of aqueous humor, thereby reducing intraocular pressure (IOP). **Analysis of Options:** * **Option A (Correct):** Latanoprost is indeed a PGF2α derivative. Unlike traditional drugs (like Beta-blockers) that decrease aqueous production, Latanoprost enhances the drainage through the unconventional uveoscleral pathway. * **Option B (Incorrect):** Selective α1 blockers (e.g., Tamsulosin, Alfuzosin) are used for BPH, but Latanoprost has no action on adrenergic receptors. * **Option C (Incorrect):** 5α-reductase inhibitors (e.g., Finasteride, Dutasteride) prevent the conversion of testosterone to DHT. Latanoprost is not a hormonal modulator. * **Option D (Incorrect):** PGE2 analogues used for cervical priming/induction of labor include **Dinoprostone**. While Latanoprost is a prostaglandin, its specific PGF2α structure and formulation are dedicated to ophthalmic use. **High-Yield Clinical Pearls for NEET-PG:** 1. **Side Effects:** The most characteristic side effects are **increased iris pigmentation** (permanent browning), **hypertrichosis** (increased eyelash growth/thickness), and **prostaglandin-associated periorbitopathy**. 2. **Dosing:** It is administered as **once-daily** eye drops (usually at night), which ensures better patient compliance compared to multi-dose regimens. 3. **Contraindication:** It should be avoided in patients with active **uveitis** or **cystoid macular edema (CME)** as it may exacerbate inflammation.

Q: Which of the following is NOT a known side effect or characteristic of beta-blockers?

Postural hypotension. **Explanation:** **1. Why Postural Hypotension is the Correct Answer:** Postural (orthostatic) hypotension is primarily caused by the blockade of **alpha-1 adrenergic receptors**, which prevents compensatory vasoconstriction when standing. Pure beta-blockers (like Propranolol or Atenolol) do not cause postural hypotension because they do not affect alpha receptors; instead, they may cause a modest decrease in blood pressure through reduced cardiac output and renin inhibition. *Note:* Mixed alpha/beta-blockers like **Labetalol** or **Carvedilol** can cause postural hypotension, but it is not a characteristic of the beta-blocker class as a whole. **2. Analysis of Incorrect Options:** * **B. Bradycardia:** This is a classic pharmacological effect. Beta-1 blockade at the SA node decreases heart rate (negative chronotropy). * **C. Glucagon for toxicity:** Glucagon is the **antidote of choice** for beta-blocker overdose. It bypasses the blocked beta-receptors to increase intracellular cAMP via glucagon receptors, restoring heart rate and contractility. * **D. Lipid solubility and bad dreams:** Lipophilic beta-blockers (e.g., **Propranolol**, Metoprolol) easily cross the blood-brain barrier. This leads to CNS side effects such as vivid dreams, nightmares, and depression. **3. NEET-PG High-Yield Pearls:** * **Water-soluble (Renal excretion):** Atenolol, Sotalol, Nadolol (Mnemonic: **A**ll **S**afe **N**ow). * **Lipid-soluble (Hepatic metabolism):** Propranolol, Metoprolol. * **Contraindications:** Always avoid beta-blockers in patients with **Prinzmetal angina** (causes unopposed alpha-vasoconstriction) and **Asthma/COPD** (due to bronchospasm from Beta-2 blockade). * **Diabetes:** They can mask the tachycardic warning signs of hypoglycemia.

Q: Which of the following adverse drug reactions is caused by Apraclonidine?

Apraclonidine. Apraclonidine is a selective alpha-2 (α2) adrenergic agonist primarily used to control or prevent post-surgical elevations in intraocular pressure (IOP) after laser procedures [1]. The question asks for a drug that causes a specific adverse reaction (implied by the context of the options provided). Apraclonidine is notorious for causing local allergic reactions, specifically blepharoconjunctivitis (itching, hyperemia, and lid edema). Because of this high incidence of follicular conjunctivitis and tachyphylaxis (loss of efficacy over time), it is restricted to short-term use rather than chronic glaucoma management. Analysis of Options: * A. Pilocarpine: A miotic (cholinergic agonist). Its classic side effects include miosis, brow ache (ciliary muscle contraction), and retinal detachment [2]. It does not typically cause the allergic blepharoconjunctivitis associated with alpha-agonists. * C. Brimonidine: Also an α2 agonist, but it is more selective and lipid-soluble than Apraclonidine. While it can cause similar reactions, it has a lower incidence of ocular allergy, making it suitable for long-term therapy [1]. * D. Latanoprost: A Prostaglandin analog. Its signature side effects are increased iris pigmentation (permanent), eyelash thickening, and hypertrichosis. NEET-PG High-Yield Pearls: * Mechanism: Apraclonidine reduces IOP by decreasing aqueous humor production [3]. * Clinical Use: Prophylaxis against IOP spikes after Argon Laser Trabeculoplasty (ALT) or Iridotomy [1]. * Lid Retraction: Unlike other glaucoma drugs, Apraclonidine can cause eyelid retraction due to its weak α1 activity on Müller’s muscle. * Horner’s Syndrome: Apraclonidine is used as a diagnostic test; it reverses ptosis in a Horner’s eye due to denervation supersensitivity of α1 receptors [4].

Q: What is the drug of choice for the management of hypertension in a patient with pheochromocytoma?

Phenoxybenzamine. Pheochromocytoma is a catecholamine-secreting tumor (epinephrine and norepinephrine) that causes severe hypertension via excessive stimulation of alpha-1 receptors [2]. **Phenoxybenzamine** is the drug of choice for preoperative management because it is an **irreversible, non-competitive, non-selective alpha-blocker** [1, 2]. Its irreversible nature ensures that even if there is a massive surge of catecholamines (e.g., during surgical manipulation of the tumor), the receptors remain blocked, preventing a hypertensive crisis [1, 2]. It is typically started 10–14 days before surgery to allow for blood pressure control and expansion of the contracted intravascular volume [1, 3]. **2. Why the Other Options are Incorrect:** * **Phentolamine:** While it is a non-selective alpha-blocker, it is **reversible and competitive**. * **Labetalol:** Although it has both alpha and beta-blocking properties, the **beta-to-alpha blockade ratio is high (approx. 3:1)**. Using it as monotherapy can lead to "unopposed alpha stimulation," causing a paradoxical rise in blood pressure [1]. * **Esmolol:** This is a short-acting beta-1 selective blocker. Beta-blockers should **never** be used alone in pheochromocytoma; they must only be introduced *after* adequate alpha-blockade is established to prevent hypertensive crisis [1]. **3. NEET-PG Clinical Pearls:** * **The Golden Rule:** Always "Alpha before Beta." Start alpha-blockers first, then add beta-blockers (usually 2-3 days later) to manage tachycardia [1]. * **Rule of 10s:** Pheochromocytoma is 10% bilateral, 10% malignant, 10% pediatric, 10% extra-adrenal (Paraganglioma), and 10% familial. * **Metyrosine:** An adjuvant drug that inhibits *Tyrosine Hydroxylase* (the rate-limiting enzyme in catecholamine synthesis), used in inoperable or malignant cases.

Q: What is the most potent cardiac stimulant among the following?

Adrenaline. **Explanation:** **Adrenaline (Epinephrine)** is the most potent cardiac stimulant because it is a potent agonist at **$\beta_1$, $\beta_2$, and $\alpha$ receptors**. Its action on $\beta_1$ receptors in the myocardium leads to a powerful increase in heart rate (positive chronotropy), force of contraction (positive inotropy), and conduction velocity (positive dromotropy). Unlike other catecholamines, it significantly increases cardiac output while simultaneously maintaining or increasing coronary perfusion. **Analysis of Options:** * **Noradrenaline:** While it has strong $\beta_1$ activity, its potent $\alpha_1$ action causes marked peripheral vasoconstriction. This triggers a **reflex bradycardia** via the baroreceptor reflex, which often offsets its direct stimulatory effects on the heart rate. * **Ephedrine:** This is a mixed-acting sympathomimetic. It is significantly **less potent** than adrenaline because it acts partly by releasing endogenous noradrenaline and has a lower affinity for adrenergic receptors. * **Salbutamol:** This is a **selective $\beta_2$ agonist**. While it can cause tachycardia (via direct $\beta_2$ stimulation in the heart and reflex tachycardia due to vasodilation), it lacks the powerful $\beta_1$ and $\alpha$ mediated cardiac support provided by adrenaline. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Adrenaline is the DOC for **Anaphylactic Shock** (1:1000 IM) and **Cardiac Arrest** (1:10,000 IV). * **Vasomotor Reversal of Dale:** This phenomenon occurs when adrenaline is given after an $\alpha$-blocker, resulting in a fall in BP due to unopposed $\beta_2$ action. * **Metabolism:** Catecholamines like adrenaline are rapidly degraded by **COMT and MAO**, explaining their short duration of action.

Q: Which of the following is an endogenous catecholamine?

Dobutamine. The question asks to identify which of the listed options is **NOT** an endogenous catecholamine (based on the provided answer key where Dobutamine is marked correct). **1. Why Dobutamine is the Correct Answer:** Catecholamines are compounds containing a catechol nucleus and an amine group. They are classified into two types: * **Endogenous:** Naturally produced within the body (Dopamine, Epinephrine/Adrenaline, and Norepinephrine/Noradrenaline) [1]. * **Synthetic:** Man-made compounds designed to mimic the effects of endogenous catecholamines. **Dobutamine** is a synthetic catecholamine primarily used as a selective $\beta_1$-agonist to increase cardiac output in heart failure and cardiogenic shock. It is not produced naturally by the human body. **2. Analysis of Incorrect Options:** * **A. Dopamine:** A naturally occurring metabolic precursor of norepinephrine [3]. It acts as a neurotransmitter in the CNS and a hormone in the periphery. * **C. Adrenaline (Epinephrine):** Produced primarily by the adrenal medulla; it is the chief hormone of the "fight or flight" response [1]. * **D. Noradrenaline (Norepinephrine):** The primary neurotransmitter of most postganglionic sympathetic neurons and a precursor to adrenaline [1]. **3. NEET-PG Clinical Pearls:** * **Biosynthesis Pathway:** Tyrosine $\rightarrow$ L-Dopa $ ightarrow$ Dopamine $ ightarrow$ Noradrenaline $ ightarrow$ Adrenaline [1], [2]. * **Rate-limiting enzyme:** Tyrosine hydroxylase. * **Metabolism:** Catecholamines are metabolized by **MAO** (Monoamine oxidase) and **COMT** (Catechol-O-methyltransferase). The end product of Adrenaline/Noradrenaline metabolism is **VMA** (Vanillylmandellic acid), which is elevated in Pheochromocytoma [4]. * **Isoprenaline** is another common synthetic catecholamine (non-selective $\beta$-agonist) frequently tested in exams.

Question 1

Which of the following is a long-acting non-depolarizing muscle relaxant?

Accepted Answer

Pancuronium

Answer

Succinylcholine

Answer

Mivacurium

Answer

Phenylephrine

Question 2

A child has swallowed the contents of two bottles of nasal decongestant, whose primary ingredient is an alpha-adrenergic receptor agonist. What signs of alpha activation may occur in this patient?

Accepted Answer

Mydriasis (pupil dilation)

Answer

Tachycardia

Answer

Vasoconstriction

Answer

All the above

Question 3

Which of the following drugs will decrease heart rate in a patient with a normal heart rate but will have little effect on heart rate in a cardiac transplant recipient?

Accepted Answer

Phenylephrine

Answer

Adrenaline

Answer

Noradrenaline

Answer

Isoproterenol

Question 4

Latanoprost is a relatively newer agent. Which of the following statements is true regarding this agent?

Accepted Answer

It is a PGF2a derivative used in glaucoma.

Answer

It is a selective a1 blocker used in benign hypertrophy of the prostate.

Answer

It is a 5a reductase inhibitor used to reduce the size of an enlarged prostate gland.

Answer

It is a PGE2 analogue used intravaginally for cervical priming.

Question 5

Which of the following is NOT a known side effect or characteristic of beta-blockers?

Accepted Answer

Postural hypotension

Answer

Bradycardia

Answer

Glucagon used for toxicity

Answer

Lipid soluble drugs cause bad dreams

Question 6

Which of the following adverse drug reactions is caused by Apraclonidine?

Accepted Answer

Apraclonidine

Answer

Pilocarpine

Answer

Brimonidine

Answer

Latanoprost

Question 7

What is the drug of choice for the management of hypertension in a patient with pheochromocytoma?

Accepted Answer

Phenoxybenzamine

Answer

Phentolamine

Answer

Labetalol

Answer

Esmolol

Question 8

What is the most potent cardiac stimulant among the following?

Accepted Answer

Adrenaline

Answer

Noradrenaline

Answer

Ephedrine

Answer

Salbutamol

Question 9

Which of the following is an endogenous catecholamine?

Accepted Answer

Dobutamine

Answer

Dopamine

Answer

Adrenaline

Answer

Noradrenaline

Question 10

A physician used edrophonium to differentiate between a myasthenic crisis and a cholinergic crisis. What property makes it preferred over other anticholinesterase agents for this purpose?

Accepted Answer

Shorter duration of action

Answer

Longer duration of action

Answer

Direct action on the muscle end plate

Answer

Selective inhibition of true cholinesterase

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?